SEC Form 4 · accession 0001179110-18-012642
Traws Pharma, Inc. · TRAW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Charles Woodman
Officer — Chief Medical Officer
Period of report
Nov 5, 2018
Accepted (ET)
Nov 7, 2018 · 5:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001130598
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.82 | Nov 5, 2018 | A | 20,000 | A | — | Nov 5, 2028 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1These options vest over 4 years. 25% on the first anniversary of the grant date and the remainder in 36 equal monthly installments over the last 3 years.